Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Growth Projections For The Coronary Atherectomy Devices Market Size During 2025–2029?
The overall valuation of the coronary atherectomy devices sector has experienced significant upward momentum recently, projected to increase from its $0.21 billion standing in 2024 to $0.23 billion by 2025, reflecting an 8.8% compound annual growth rate; this historical expansion phase is fundamentally driven by the increasing incidence of cardiac vessel blockages, the escalating preference for surgical interventions that involve less disruption, the market’s own need for atherectomy tools, and broader financial capacity among consumers.
Projections indicate a robust expansion for the coronary atherectomy devices sector over the upcoming years, anticipated to reach a market valuation of $0.34 billion by 2029, driven by a compound annual growth rate (CAGR) of 9.8%; this upward trajectory in the projected timeframe is fueled by demographic shifts toward an older population, the rise of hybrid procedural approaches, increased financial commitment from industry players, and greater knowledge among both patients and medical practitioners, while key developments shaping this period involve innovations in the devices themselves, the trend toward smaller components, superior visualization capabilities, tailored medical interventions, improvements in device engineering, and the integration of robotics and artificial intelligence.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3345&type=smp
What Are The Top Growth Drivers Impacting The Coronary Atherectomy Devices Market Outlook?
A rise in cardiovascular disease occurrences, stemming from elements such as smoking habits, insufficient physical activity, and poor dietary choices, has consequently boosted the need for atherectomy instruments in managing these conditions. Evidence supporting this trend includes data from the US government agency, the Center for Disease Control and Prevention, which reported 695,547 fatalities from cardiovascular ailments in 2021 as of September 2023. Furthermore, projections released by the American College of Cardiology, a US non-profit medical organization, indicated in August 2022 that risk factors associated with ischemic heart disease were anticipated to climb by 30.7 percent, reaching 29 million cases by the year 2025, thereby suggesting that the expanding scope of cardiovascular illness will be a primary catalyst for market expansion in the worldwide coronary atherectomy device sector.
What Are The Emerging Segments Gaining Attention In The Coronary Atherectomy Devices Market?
The coronary atherectomy devicesmarket covered in this report is segmented –
1) By Product: Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Other Products
2) By Application: Peripheral Vascular, Cardiovascular, Neurovascular
3) By End User: Hospitals And Surgical Centers, Ambulatory Care Centers, Research Laboratories And Academic Institutes
Subsegments:
1) By Directional Atherectomy Devices: Traditional Directional Atherectomy Devices, Advanced Directional Atherectomy Devices
2) By Orbital Atherectomy Devices: Single-Wire Orbital Atherectomy Devices, Multi-Wire Orbital Atherectomy Devices
3) By Photo-Ablative Atherectomy Devices: Laser-Based Photo-Ablative Devices, Other Photo-Ablative Atherectomy Devices
4) By Rotational Atherectomy Devices: Manual Rotational Atherectomy Devices, Motorized Rotational Atherectomy Devices
5) By Other Products: Combination Atherectomy Devices, Custom Atherectomy Solutions, Other Coronary Atherectomy Devices
Which Market Trends Are Creating New Opportunities In The Coronary Atherectomy Devices Industry?
Leading firms within the coronary atherectomy apparatus sector are concentrating efforts on pioneering advancements, exemplified by radial access catheters, aiming to enhance patient prognoses via procedures that are both safer and less invasive for addressing coronary artery illness. These Radial Access Catheters are particular pieces of medical hardware employed in cardiology interventions, facilitating entry into the coronary arteries through the wrist’s radial artery, a departure from the conventional femoral artery route in the groin area. To illustrate, AngioDynamics, an American firm furnishing various products and remedies to medical practitioners, publicly disclosed in January 2024 the FDA 510(k) authorization for its Auryon XL Radial Access Catheter, specifically engineered for managing peripheral arterial disease (PAD). This particular catheter, measuring 225-cm in length and designed to integrate seamlessly with the Auryon Atherectomy System, is available in two distinct diameter specifications (0.9 mm and 1.5 mm) and leverages sophisticated laser methods to efficiently address arterial blockages. A key advantage of employing the radial approach is the considerable decrease in the likelihood of major hemorrhage when contrasted with the conventional femoral method, moreover, it facilitates addressing diseased areas on both sides during the same appointment, thereby accelerating the recuperation process.
Who Are The Prominent Global Companies Shaping The Coronary Atherectomy Devices Market?
Major companies operating in the coronary atherectomy devices market include Boston Scientific Corporation, Koninklijke Philips N.V., Cardiovascular Systems Inc., The Spectranetics Corporation, Medtronic Inc., Avinger Inc., Biotronik SE & Co KG, Arterial Remodeling Technologies, Atrium Medical Corporation, B. Braun Melsungen AG, Balton Sp. z o.o., Biosensors International Group Ltd., Straub Medical AG, C.R. Bard Inc., RA Medical Systems Inc., Shockwave Medical Inc., Terumo Corporation, Abbott Laboratories Inc., Asahi Intecc Co. Ltd., Baylis Medical Company Inc., Cook Medical LLC, Cordis Corporation, Edwards Lifesciences Corporation, Endologix Inc., Infraredx Inc., Intact Vascular Inc., Lutonix Inc., Mercator MedSystems Inc., Miracor Medical Systems GmbH, OrbusNeich Medical Company Limited, QT Vascular Ltd., TriReme Medical LLC, Vascular Solutions Inc., Volcano Corporation
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/coronary-atherectomy-devices-global-market-report
Which Region Currently Holds The Largest Share Of The Coronary Atherectomy Devices Market?
North America was the largest region in the coronary atherectomy devices market in 2024. Western Europe was the second-largest region in the global coronary atherectomy devices market share. Africa, was the smallest region in the coronary atherectomy devices industry. The regions covered in the coronary atherectomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Request A Customized Version Of The Coronary Atherectomy Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=3345&type=smp
Browse Through More Reports Similar to the Global Coronary Atherectomy Devices Market 2025, By The Business Research Company
Bifurcation Lesions Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bifurcation-lesions-global-market-report
Vascular Grafts Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vascular-grafts-global-market-report
Vascular Endothelial Growth Factor Inhibitors Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model